Presentation is loading. Please wait.

Presentation is loading. Please wait.

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

Published byOpal Dennis Modified over 6 years ago

Similar presentations

Presentation on theme: "171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and."— Presentation transcript:

1 171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) knowledge translation program  S.G. Goodman, C.R. Kerr, M.S. Green, D.J. Gladstone, A. Mendelsohn, L.B. Mitchell, C. Fournier, J.L. Cox, M. Talajic, P.J. Lin, A. Langer, P. Dorian  Canadian Journal of Cardiology  Volume 27, Issue 5, (September 2011) DOI: /j.cjca Copyright © 2011 Canadian Cardiovascular Society Terms and Conditions

2 Canadian Journal of Cardiology 2011 27, DOI: (10. 1016/j. cjca. 2011
Copyright © 2011 Canadian Cardiovascular Society Terms and Conditions

Download ppt "171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and."

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
PLATELET REACTIVITY, P2Y12 RECEPTOR INHIBITOR SELECTION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS.

PLATELET REACTIVITY, P2Y12 RECEPTOR INHIBITOR SELECTION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS.
DOES IT MATTER WHICH SURGEON WORKS WITH WHICH ASSISTANT

DOES IT MATTER WHICH SURGEON WORKS WITH WHICH ASSISTANT
Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
HOMOGRAFT VERSUS CONVENTIONAL PROSTHESIS FOR SURGICAL MANAGEMENT OF AORTIC VALVE INFECTIVE ENDOCARDITIS A SYSTEMATIC REVIEW AND META-ANALYSIS  B. Yanagawa,

HOMOGRAFT VERSUS CONVENTIONAL PROSTHESIS FOR SURGICAL MANAGEMENT OF AORTIC VALVE INFECTIVE ENDOCARDITIS A SYSTEMATIC REVIEW AND META-ANALYSIS  B. Yanagawa,
904 Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial  K. Blom, B. Baker, M.

904 Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial  K. Blom, B. Baker, M.
ISCHEMIC AND BLEEDING EVENTS IN CANADIAN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHO REQUIRE ORAL ANTICOAGULATION:

ISCHEMIC AND BLEEDING EVENTS IN CANADIAN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHO REQUIRE ORAL ANTICOAGULATION:
Robert Roberts, MD, FRCPC, MACC  Canadian Journal of Cardiology 

Robert Roberts, MD, FRCPC, MACC  Canadian Journal of Cardiology 
273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E.

273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention 

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention 
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
CONTRIBUTION OF AORTIC REGURGITATION TO LEFT VENTRICLE LOAD IN PATIENTS WITH AORTIC STENOSIS: A MATHEMATICAL MODEL ANALYSIS  A. Djebbari, W. Mawad, N.

CONTRIBUTION OF AORTIC REGURGITATION TO LEFT VENTRICLE LOAD IN PATIENTS WITH AORTIC STENOSIS: A MATHEMATICAL MODEL ANALYSIS  A. Djebbari, W. Mawad, N.
The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,
166 Correlation Between Cytochrome P450 2C19 Enzymatic Activity Assessed by [13C]-Pantoprazole Breath Test and Platelet Reactivity in Patients Treated.

166 Correlation Between Cytochrome P450 2C19 Enzymatic Activity Assessed by [13C]-Pantoprazole Breath Test and Platelet Reactivity in Patients Treated.
517 Cyclosporine-A Mediated Inhibition of Nrf2 Nuclear Localization and Reduction in Superoxide Activity is Rescued by Tert-Butylhydroquinone in Human.

517 Cyclosporine-A Mediated Inhibition of Nrf2 Nuclear Localization and Reduction in Superoxide Activity is Rescued by Tert-Butylhydroquinone in Human.
The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines  Laurent Macle, MD,

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines  Laurent Macle, MD,

Similar presentations

Ads by Google